Annual banned-substance review Research articles Contents continued overleaf 8(1) (2016) ISSN

Similar documents
WADA Technical Document TD2017MRPL

Fiona Coope (BSc) Forensics Director

DART MSI of drugs of abuse in hair

The 2018 Prohibited List will be effective 1 January As usual there are some changes.

SCREENING OF NEW PSYCHOACTIVE SUBSTANCES IN URINE SAMPLES BY HIGH RESOLUTION MASS SPECTROMETRY

Detection of Cannabinoids in Oral Fluid with the Agilent 7010 GC-MS/MS System

Application. Detection of Cannabinoids in Oral Fluid Using Inert Source GC/MS. Introduction. Authors. Abstract. Forensic Toxicology

Detection of synthetic cannabinoids in hair

Analytic Techniques Utilisedfor Drug Checking

Quantitative Analysis of Drugs of Abuse in Urine using UHPLC Coupled to Accurate Mass AxION 2 TOF Mass Spectrometer

Enantiomeric Separation of Clenbuterol as Analytical Strategy to Distinguish Abuse from Meat Contamination

Objectives. Why new drugs? New drugs of abuse: synthetic cannabinoids, stimulants, and 10/14/2015. Describe several new drugs of abuse

First experiences with GC-C-IRMS to detect natural hormone abuse in cattle. Dr. Eva de Rijke RIKILT Wageningen UR

Qualitative and quantitative determination of cannabinoid profiles and potency in CBD hemp oil using LC/UV and Mass Selective Detection

DETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS

Novel psychoactive substances in postmortem toxicology. Pirkko Kriikku, PhD Forensic Toxicologist

A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS

2009 Prohibited List

SmartNotes. Why test for synthetic cannabinoids? Synthetic Cannabinoids Facts

Payment Policy: Urine Specimen Validity Testing Reference Number: CC.PP.056 Product Types: ALL Effective Date: 11/01/2017 Last Review Date:

Designer Fentanyls Drugs that kill and how to detect them. Cyclopropylfentanyl

T R A I N I N G G U I D E

The Challenges of Analytical Method Validation for Hallucinogens and Designer Stimulants in Biological Samples Using LC-TOF

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Payment Policy Drug Testing EFFECTIVE DATE: POLICY LAST UPDATED:

[ APPLICATION NOTE ] The Separation of 8 -THC, 9 -THC, and Their Enantiomers by UPC 2 Using Trefoil Chiral Columns INTRODUCTION APPLICATION BENEFITS

Conventional and emerging drugs of abuse: the current situation

Cannabinoid Profiling and Quantitation in Hemp Extracts using the Agilent 1290 Infinity II/6230B LC/TOF system

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: January 1, Related Policies None

NIH Public Access Author Manuscript Clin Chem. Author manuscript; available in PMC 2013 July 21.

Detection of Drugs-of-Abuse by Tandem Mass Spectrometry.

Urine Testing and Abuse Patterns of Drugs and New Psychoactive Substances Application of Comprehensive Time-of-Flight Mass Spectrometry

Urine drug testing it s not always crystal clear

MEDICAL POLICY Drug Testing

Rapid Hydrolysis of Benzodiazepines in Urine. Alicia Zook 1 and Crystal Xander B.S. 2. Cedar Crest College, Allentown, PA 1

Metabolomics: quantifying the phenotype

Flakka : The Truth Behind the Latest Designer Drug Media Storm. Donna Papsun, MS, D-ABFT-FT Forensic Toxicologist, NMS Labs

The Drug Testing Process. Employer or Practice

Substances under Surveillance

MEDICAL POLICY Drug Testing

Rapid and Robust Detection of THC and Its Metabolites in Blood

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: March 1, Related Policies None

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: October 1, Related Policies None

SECTION 1 LEARNING OBJECTIVES:

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative

WADA Technical Document TD2017CG/LH

Identifying New Cannabis Use with Urine Creatinine- Normalized THCCOOH Concentrations and Time Intervals Between Specimen Collections *

Quantitative Analysis of THC and Main Metabolites in Whole Blood Using Tandem Mass Spectrometry and Automated Online Sample Preparation

MARIHUANA AND DRIVING: WHAT IS THE SIGNIFICANCE OF CANNABINOID CONCENTRATIONS? * * A. McBay, M.D. ; and A. P. Mason SYNOPSIS

Recent changes and new trends observed regarding drug use

Altering Perception and Dirty Deeds. Forensic Science Part #D

Drug Testing Policy. Reimbursement Policy CMS Approved By. Policy Number. Annual Approval Date. Reimbursement Policy Oversight Committee

Drug Testing Policy. Approved By 05/10/2017. Application This reimbursement policy applies to UnitedHealthcare Community Plan Medicaid products.

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain

When Anti-Doping reveals pathology an Australian experience

POLICY NUMBER: POL 153

Opiates, Opioids and Benzodiazepines, Amphetamines & Illicit Drug Forensic Analysis by LC/MS

New patterns of drug use in Hungary

National Drug Intelligence Bureau. Environmental Science and Research

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Simultaneous Determination of Prescription and Designer Benzodiazepines in Urine and Blood by SPE and LC-MS/MS

Fast and easy separation of 23 drugs of abuse. including high, stable resolution of isobaric opioids from human urine by UHPLC-MS/MS

Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry

Possibility of Use a Saliva for Determination Ethanol and Opiates

2. Ionization Sources 3. Mass Analyzers 4. Tandem Mass Spectrometry

Drug Profiles of Apprehended Drivers in Victoria

Drug Testing Policy. Approved By 06/14/2017

Extraction of Synthetic and Naturally Occurring Cannabinoids in Urine Using SPE and LC-MS/MS

Learning Objectives. Drug Testing 10/17/2012. Utilization of the urine drug screen: The good, the bad, and the ugly

CHD 110 PSYCHOPHARMACOLOGY AND SUBSTANCE ABUSE

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Solving practical problems. Maria Kuhtinskaja

The Challenge of New Psychoactive Substances (NPS) A Presentation for CAD by Dr Des Corrigan October 2015

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Detection and characterization of urinary metabolites of boldione. Part I: phase I

Forensic Toxicology Findings in DRDs. Dr Hazel Torrance Manager of the Forensic Toxicology Service Forensic Medicine and Science

SPICE Prevention Issues Measures in Switzerland in the fight against new drugs such as SPICE and bath salts

Metabolism of new synthetic cannabinoids and detection of metabolites in urine samples

Real-time PK Measurement of the Chemotherapeutic Drug Melphalan in Whole Blood by a Novel PaperSpray Mass Spectrometry

Several possible toxicological and genetic tools for the extension of the detection window after GHB intake

Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens

Workflow for Screening and Quantification of the SAMHSA (NIDA) Panel in Urine Using UHPLC-TOF

2017 Drug Screen Tests

Challenges of New Emerging Designer Drugs

Drug Testing Policy. Reimbursement Policy CMS Approved By. Policy Number. Annual Approval Date. Reimbursement Policy Oversight Committee

Comprehensive Forensic Toxicology Screening in Serum using On-Line SPE LC-MS/MS

Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082

A review of the collision induced dissociation fragmentation and the metabolism of synthetic cathinone derivatives

Earlier arrests among apprehended drivers in Norway with heroin and ecstasy detection

Quantitative Method for Amphetamines, Phentermine, and Designer Stimulants Using an Agilent 6430 LC/MS/MS

LOCALISATION, IDENTIFICATION AND SEPARATION OF MOLECULES. Gilles Frache Materials Characterization Day October 14 th 2016

NARCOTIC NOTES FLIPBOOK BY: PER:

Drug Threats in the United States: 2019 Update

Workflow for Screening and Quantification of the SAMHSA (NIDA) Panel in Serum Using UHPLC-TOF

Lab Tests Made Simple

Fast and simultaneous analysis of ethanol metabolites and barbiturates using the QTRAP 4500 LC-MS/MS system

Jennifer P. Pascali, PhD. dtolabs, Resana (TV)

Transcription:

1 Volume 8 Number 1, January 2016 Annual banned-substance review Detection assays for drugs and methods of sports doping published between 2014 and 2015 are critically reviewed and evaluated in context with the Prohibited List 2015 as established by the World Anti-Doping Agency. Annual banned-substance review: analytical approaches in human sports drug testing 7 29 M. Thevis, T. Kuuranne, K. Walpurgis, H. Geyer and W. Schänzer Research articles The development of the first fully automated method for the determination of opioids in dried blood spots is described. Selective, sensitive, accurate, and reproducible quantitation of five representative opioids at sub therapeutic, therapeutic, and toxic levels can be achieved within 5 min. Quantitative determination of opioids in whole blood using fully automated dried blood spot desorption coupled to on line SPE LC MS/MS 30 38 R. Verplaetse and J. Henion Comprehensive UHPLC HR TOF MS based confirmation level screening was employed to determine the accurate drug abuse patterns of drug users with different attendance for drug treatment. Those subjects regularly attending treatment mainly abused medicinal buprenorphine and benzodiazepines. Conversely, the conventional illicit drugs amphetamine and cannabis were more frequent among the subjects irregularly attending treatment, together with a higher rate of new psychoactive substances and polydrug abuse. Treatment of drug abusers thus could be valuable in reducing polydrug abuse. Patterns of drug abuse among drug users with regular and irregular attendance for treatment as detected by comprehensive UHPLC HR TOF MS 39 45 M. Sundström, A. Pelander, K. Simojoki and I. Ojanperä 8(1) 1 148 (2016) ISSN 1942-7603

Reviews β Glucan is a valuable molecule molecule for the human and animal health system. The yeast cell wall, particularly of baker's and brewer's yeast Saccharomyces cerevisiae, is an important source of β D glucans. For yeast β glucan, many extraction methods have been proposed. Yeast cells can be exploited for β glucan production. Brewery and winery spent yeast biomass can comprise an alternative source for β glucan production. An evaluation study of different methods for the production of β D glucan from yeast biomass 46-55 V. Varelas, M. Liouni, A. C. Calokerinos and E. T. Nerantzis Literature review suggests cannabinoid analysis as essential requirement to estimate the time of last cannabis intake supporting a temporal relationship between marijuana smoking and CVD. Any scientific interference about a causal link between cannabis use and CVD remains plausible but not completely established. Coronary thrombosis and marijuana smoking: a case report and narrative review of the literature 56-62 D. Marchetti, A. Spagnolo, V. De Matteis, L. Filograna and N. De Giovanni During the three year period of 2012 2014 we have found the new psychoactive substances (NPS) in 112 cases. The drugs detected were: 3 MMC, α PVP, MDPBP, UR 144, ethcathinone, mephedrone, MDPV, 4 MEC, buphedrone, 2 DPMP, methylone and 2C B. In single cases, 2 MMC, 2C P, eutylone, 25I NBOMe, mcpp, ephedrone, MPA and 5 APB were found. The prevalence of new psychoactive substances in biological material a threeyear review of casework in Poland 63-70 P. Adamowicz, J. Gieroń, D. Gil, W. Lechowicz, A. Skulska and B. Tokarczyk 2

3 Pharmaceutical applications of NIR CI in each unit operation during the manufacturing processes, from the Western solid dosage forms to the Chinese materia medica preparations, are reviewed. PAT: From Western solid dosage forms to Chinese materia medica preparations using NIR CI 71-85 L. Zhou, M. Xu, Z. Wu, X. Shi and Y. Qiao Research articles A method is developed and validated for simultaneous screening and quantification of 24 analytes of forensic relevance in vitreous humour, blood and plasma using LC MS/MS. The method is advantageous over other methods due to its simplified sample preparation protocol and less sample requirement. The method is well applied for screening of drugs in post mortem samples collected at autopsy. Development and validation of an ESI LC MS/ MS method for simultaneous identification and quantification of 24 analytes of forensic relevance in vitreous humour, whole blood and plasma 86-97 B. Arora, T. Velpandian, R. Saxena, S. Lalwani, T. D. Dogra and S. Ghose 2 Methoxydiphenidine (2 MXP) has recently appeared as a research chemical and is suspected to show dissociative properties in humans. This study presents the identification of 2 MXP in various products obtained from test purchases from UK based vendors. Further verification was obtained by organic synthesis of three positional MXP isomers. Furthermore, the implementation of matrix assisted inlet ionization Orbitrap mass spectrometry confirmed the ability to detect the protonated molecule of 2 MXP directly from the tablet surface following addition of 3 nitrobenzonitrile as the matrix. Test purchase, synthesis, and characterization of 2 methoxydiphenidine (MXP) and differentiation from its meta and parasubstituted isomers 98 119 G. McLaughlin, N. Morris, P. V. Kavanagh, J. D. Power, J. O'Brien, B. Talbot, S. P. Elliott, J. Wallach, K. Hoang, H. Morris and S. D. Brandt

The influence of several factors in the excretion of testosterone metabolites (Δ 1 AED, Δ 6 AED, Δ 6 T and Δ 15 AD) conjugated with cysteine is evaluated. These factors are divided into sample preservation (microbial degradation and freeze/thaw cycles), endogenous factors (gender, ultradian and circadian rhythms, pregnancy and UGT2B17 polymorphism), and exogenous factors (alcohol and 5α reductase inhibitors). The results show the stability of the urinary cysteinyl steroids under the influence of many factors, proving their potential as adequate parameters to be included in screening procedures applied in doping control. Factors affecting urinary excretion of testosterone metabolites conjugated with cysteine 110 119 A. Fabregat, J. Marcos, J. Segura, R. Ventura and O. J. Pozo Short communications QTc shortening has been suggested as a method of screening for anabolic steriod abuse. This study evaluates the accuracy of such a test in a group of a long term steriod users. Prolonged androgenic anabolic steroid (AAS) induced QT interval shortening: a suitable screening tool? 120 122 N. Sculthorpe, L. Taylor and F. M. Grace A new SPE HPLC MS method was developed to measure progestins and applied for the analysis of freshwater samples from Lake Balaton. HPLC MS/MS analysis of steroid hormones in environmental water samples 123 127 P. Avar, G. Maasz, P. Takács, S. Lovas, Z. Zrinyi, R. Svigruha, A. Takátsy, L. G. Tóth and Z. Pirger 4

Handling cannabis plant material leads to a relevant and persistent contamination of hair with Δ 9 tetrahydrocannabinolic acid A (THCA A) and Δ 9 tetrahydrocannabinol (THC). Concentrations and pattern of distribution along the hair shaft are not distinguishable from typical results in hair samples of known cannabis users. In the light of the results of this study, any use of THC cut off concentrations in hair to evaluate consumption habits or frequency is strongly discouraged. Hair analysis for Δ9 tetrahydrocannabinolic acid A (THCA A) and Δ9 tetrahydrocannabinol (THC) after handling cannabis plant material 128 132 B. Moosmann, N. Roth and V. Auwärter Correspondence case report Smoking habits of italian athletes undergoing anti doping control 133 135 R. Pacifici, S. Pichini, I. Palmi, X. de la Torre and F. Botrè and the Anti-doping Commission at the Ministry of Health Application note The use of presumptive color tests for new psychoactive substances 136 140 E. Cuypers, A.-J. Bonneure and J. Tytgat Research article Following intra articular administration to exercised Thoroughbred horses isoflupredone was detected for up to 36 and 48 h in plasma and urine, respectively. Furthermore, as isoflupredone was detected in synovial fluid for up to 14 days post administration, urine and blood concentrations do not appear to be good indicators of drug concentrations at the effector site and by and by extrapolation may not be useful in determining the duration of pharmacologic effect. Disposition of isoflupredone acetate in plasma, urine and synovial fluid following intra articular administration to exercised Thoroughbred horses 141 147 H. K. Knych, L. M. Harrison, A. White and D. S. McKemie 5